|
PRIM1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.89769999293344E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.1014002477292E-10 |
| Normal-vs-Stage2 |
1.342250E-03 |
| Normal-vs-Stage3 |
1.699060E-03 |
| Normal-vs-Stage4 |
8.966600E-04 |
| Stage1-vs-Stage2 |
1.748650E-01 |
| Stage1-vs-Stage3 |
5.072300E-02 |
| Stage1-vs-Stage4 |
5.427800E-01 |
| Stage2-vs-Stage3 |
7.197800E-01 |
| Stage2-vs-Stage4 |
6.693600E-01 |
| Stage3-vs-Stage4 |
4.284400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.12819997788449E-09 |
| Normal-vs-AfricanAmerican |
5.246600E-01 |
| Normal-vs-Asian |
7.757000E-03 |
| Caucasian-vs-AfricanAmerican |
1.63240999999648E-05 |
| Caucasian-vs-Asian |
7.797000E-01 |
| AfricanAmerican-vs-Asian |
3.504500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.91889995191519E-09 |
| Normal-vs-Female |
2.09289999997253E-06 |
| Male-vs-Female |
2.071000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.019800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.28939999957767E-07 |
| Normal-vs-Age(61-80Yrs) |
1.84509999501259E-08 |
| Normal-vs-Age(81-100Yrs) |
4.332200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.748200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.939800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.296200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.948800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.934400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.750600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.561700E-04 |
| Normal-vs-Grade 2 |
1.99339988959935E-10 |
| Normal-vs-Grade 3 |
3.5181999999967E-06 |
| Normal-vs-Grade 4 |
3.172400E-02 |
| Grade 1-vs-Grade 2 |
8.211600E-01 |
| Grade 1-vs-Grade 3 |
1.780830E-01 |
| Grade 1-vs-Grade 4 |
1.061020E-01 |
| Grade 2-vs-Grade 3 |
6.064100E-02 |
| Grade 2-vs-Grade 4 |
7.567800E-02 |
| Grade 3-vs-Grade 4 |
4.719000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.68420832835636E-12 |
| Normal-vs-ccB subtype |
3.758000E-03 |
| ccA subtype-vs-ccB subtype |
1.73250000012892E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.2448000043579E-08 |
| Normal-vs-N1 |
6.779600E-02 |
| N0-vs-N1 |
9.869600E-01 |
|
|
